Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Summary Of Significant Accounting Policies [Line Items]
License revenue recognized	$ 0	$ 161,000	$ 0	$ 442,000
Accounting Standards Update 2021-04
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle accounting standards update, immaterial effect	true		true
Merck Neuromuscular License Agreement
Summary Of Significant Accounting Policies [Line Items]
License revenue recognized	$ 0	$ 5,000,000	$ 0	5,000,000
Milestone payments				$ 5,000,000